Modified Constraint-Induced Movement Therapy in Children With Hemiparetic Cerebral Palsy
The Effect of the Modified Constraint-Induced Movement Therapy Administered on Consecutive or Intermittent Days on Upper Extremity Function in Individuals With Hemiparetic Cerebral Palsy
1 other identifier
interventional
33
1 country
1
Brief Summary
Cerebral palsy (CP) is defined as a non-progressive lesion of the developing foetal or infant brain and causes variety of motor, sensory and cognitive impairments. Hemiplegic CP is the most common type of CP in term infants, involving one half of the body. In these individuals, muscle tone is reduced, and there is an inability to perform quality upper extremity movements due to increased muscle tone, increased reflexes, weakness in antagonist muscles. Due to spasticity upper extremity is present in shoulder adduction and internal rotation, elbow flexion and pronation, wrist and fingers flexed and thumb in palm position. Spontaneous movements of the upper extremity are decreased and abnormal. These individuals have a reduced upper extremity function ranging from mild incompetence to almost no use of the hand. Constraint-Induced Movement Therapy (CIMT) is designed to improve the function of the most affected limb by restricting the use of the less affected limb in individuals with unilateral upper extremity involvement and implementing an intensive motor learning-based training program. In pediatric subjects, modified CIMT (mCIMT), which is called a 'child-friendly technique', has been applied, which shows some differences from the form of CIMT in adults. In mCIMT, the restriction time was reduced, activities with the child were performed within a play frame, in the environment in which the child was accustomed, and restriction methods such as gloves, splint, sling were used. In the literature CIMT has been used mainly in children with hemiplegic CP in the pediatric population. However, there are many studies in the literature evaluating the efficacy of mCIMT in individuals with hemiplegic CP and showing beneficial effects on upper extremity speed and skills, and the duration of application restriction varies considerably. The aim of the investigator's study was to determine the effect of consecutive or intermittent implementation of mCIMT on upper extremity function in children with hemiplegic CP. Thus, it will be determined whether the modification of the duration of administration in the pediatric population varies in treatment results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2019
CompletedFirst Posted
Study publicly available on registry
August 22, 2019
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2021
CompletedFebruary 15, 2021
February 1, 2021
1 year
August 20, 2019
February 11, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Children's Hand-Use Experience Questionnaire (CHEQ)
Assessing children's experience of using the affected hand in activities of daily living where usually two hands are needed. There are 29 items at questionnaire. When respondents answered the questionnaire, they were first asked whether the activity included in the questionnaire was conducted independently. If the activities can be done independently, it is questioned whether one or two hands are used during the activities. If two hands are used, answers and scores to the following 3 sub-questions are sought: hand use, time use in comparison to peers, experience of feeling bothered while doing the activity. A higher score indicates a better level of independence.
Change from Baseline at 10 days and at 5 weeks
Jebsen-Taylor Hand Function Test
This is an objective test to evaluate hand function for a person's activities of daily living. Test consist of 7 subtests includes writing, card turning, manipulate small common objects, simulated feeding, stacking checkers, moving large light objects and moving large heavy objects. We will use 6 subtests except writing in our study.
Change from Baseline at 10 days and at 5 weeks
Secondary Outcomes (7)
Gross Motor Classification System (GMFCS)
At Baseline
Manual Ability Classification System (MACS)
At Baseline
Pediatric Balance Scale (PBS)
At Baseline
Modified Tardieu Scale (MTS)
Change from Baseline at 10 days and at 5 weeks
ABILHAND-Kids Questionnaire
Change from Baseline at 10 days and at 5 weeks
- +2 more secondary outcomes
Study Arms (3)
Consecutive mCIMT group
EXPERIMENTAL6 hours / day, 10 consecutive days, 60 hours mKZHT + 2 days 45 minutes / day traditional physiotherapy
Intermittent mCIMT group
EXPERIMENTAL6 hours / day 2 days a week 5 weeks, a total of 60 hours mKZHT + 2 days 45 min / day traditional physiotherapy
Traditional physiotherapy control group
ACTIVE COMPARATOR45 min / day, 2 days a week traditional physiotherapy
Interventions
Consecutive mCIMT group received 6 hours per day mCIMT sessions for consecutive 10 days. Accompanied by a physiotherapist in 1 hour of the 6-hour restriction period, the family was guided within the remaining period and the activities were adapted to daily life.
Traditional physiotherapy within a specific program
Intermittent mCIMT group received mCIMT session 6 hours per day for 10 days, spread over 5 weeks (two days per week). Accompanied by a physiotherapist in 1 hour of the 6-hour restriction period, the family was guided within the remaining period and the activities were adapted to daily life.
Eligibility Criteria
You may qualify if:
- confirmed diagnosis of hemiplegic CP
- years of age
- MACS level I, II or III
- GMFCS level I
- To have sufficient communication skills
- To be able to extend the wrist at least 20 degrees
- Lack of severe spasticity to prevent grasping and dropping objects
- Surgery or application of Botulinum toxin within the last 6 months
- The family's acceptance of the child's participation in the study
- The child volunteers to participate in the study
You may not qualify if:
- Visual and hearing impairment
- Family refuses to participate in the study
- There is a walking and balance problem that may cause a fall risk during the use of a sling
- Behavioral problems at the level to reject the practices to be performed within the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abant Izzet Baysal University
Bolu, 14280, Turkey (Türkiye)
Related Publications (4)
Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics. 2004 Feb;113(2):305-12. doi: 10.1542/peds.113.2.305.
PMID: 14754942BACKGROUNDBrady K, Garcia T. Constraint-induced movement therapy (CIMT): pediatric applications. Dev Disabil Res Rev. 2009;15(2):102-11. doi: 10.1002/ddrr.59.
PMID: 19489088BACKGROUNDHoare BJ, Wasiak J, Imms C, Carey L. Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004149. doi: 10.1002/14651858.CD004149.pub2.
PMID: 17443542BACKGROUNDStearns GE, Burtner P, Keenan KM, Qualls C, Phillips J. Effects of constraint-induced movement therapy on hand skills and muscle recruitment of children with spastic hemiplegic cerebral palsy. NeuroRehabilitation. 2009;24(2):95-108. doi: 10.3233/NRE-2009-0459.
PMID: 19339749BACKGROUND
Study Officials
- STUDY DIRECTOR
Tamer Çankaya
Abant Izzet Baysal University
- PRINCIPAL INVESTIGATOR
Sezen Tezcan
Abant Izzet Baysal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 20, 2019
First Posted
August 22, 2019
Study Start
September 1, 2019
Primary Completion
September 15, 2020
Study Completion
January 8, 2021
Last Updated
February 15, 2021
Record last verified: 2021-02